These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 33766539)

  • 1. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
    Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
    Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
    Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
    J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of SLC9A8 Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer Cells via the IL6-JAK1/STAT3 Signaling Pathway.
    Liu W; Geng C; Li X; Li Y; Song S; Wang C
    Dig Dis Sci; 2023 May; 68(5):1873-1884. PubMed ID: 36583805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway.
    Zhang Q; Di J; Ji Z; Mi A; Li Q; Du X; Wang A; Wang A; Qin C
    Dis Markers; 2020; 2020():2032679. PubMed ID: 32695240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
    He T; Cui J; Wu Y; Sun X; Chen N
    Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced phosphoprotein 1 facilitates breast cancer cell progression and indicates poor prognosis for breast cancer patients.
    Lin L; Wen J; Lin B; Xia E; Zheng C; Ye L; Wang Y; Wang O; Chen Y
    Hum Cell; 2021 May; 34(3):901-917. PubMed ID: 33665786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.
    Ma J; Zhao J; Lu J; Wang P; Feng H; Zong Y; Ou B; Zheng M; Lu A
    Tumour Biol; 2016 Jul; 37(7):9077-88. PubMed ID: 26762412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties and Clinical Relevance of Speckle-Type POZ Protein in Human Colorectal Cancer.
    Xu J; Wang F; Jiang H; Jiang Y; Chen J; Qin J
    J Gastrointest Surg; 2015 Aug; 19(8):1484-96. PubMed ID: 26022775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of PYCR1 inhibits proliferation, drug resistance and EMT in colorectal cancer cells by regulating STAT3-Mediated p38 MAPK and NF-κB signalling pathway.
    Yan K; Xu X; Wu T; Li J; Cao G; Li Y; Ji Z
    Biochem Biophys Res Commun; 2019 Dec; 520(2):486-491. PubMed ID: 31606203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
    Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y
    Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
    Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
    Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEP Domain Containing 1 Promotes Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Colorectal Cancer by Enhancing Expression of Suppressor of Zest 12.
    Wang Q; Jiang S; Liu J; Ma G; Zheng J; Zhang Y
    Cancer Biother Radiopharm; 2021 Feb; 36(1):36-44. PubMed ID: 32343606
    [No Abstract]   [Full Text] [Related]  

  • 15. LncRNA AB073614 induces epithelial- mesenchymal transition of colorectal cancer cells via regulating the JAK/STAT3 pathway.
    Xue J; Liao L; Yin F; Kuang H; Zhou X; Wang Y
    Cancer Biomark; 2018; 21(4):849-858. PubMed ID: 29439310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Downregulation of Ribosomal Protein L34 Restricts the Proliferation and Metastasis of Colorectal Cancer by Suppressing the
    Liang YC; Li R; Bao SR; Li ZL; Yin HZ; Dai CL
    Hum Gene Ther; 2023 Aug; 34(15-16):719-731. PubMed ID: 37427415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased EWSAT1 expression promotes cell proliferation, invasion and epithelial-mesenchymal transition in colorectal cancer.
    Zhang R; Li JB; Yan XF; Jin K; Li WY; Xu J; Zhao J; Bai JH; Chen YZ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6801-6808. PubMed ID: 30402843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑129 inhibits colorectal cancer cell proliferation, invasion and epithelial‑to‑mesenchymal transition by targeting SOX4.
    Chen Z; Zhong T; Zhong J; Tang Y; Ling B; Wang L
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
    J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
    Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
    Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.